- Home
- USIO vs COCH Comparison
USIO vs COCH Comparison
Compare USIO & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USIO
- COCH
- Stock Information
- Founded
- USIO 1998
- COCH 1995
- Country
- USIO United States
- COCH United States
- Employees
- USIO N/A
- COCH N/A
- Industry
- USIO Investment Bankers/Brokers/Service
- COCH Blank Checks
- Sector
- USIO Finance
- COCH Finance
- Exchange
- USIO Nasdaq
- COCH Nasdaq
- Market Cap
- USIO 36.6M
- COCH 31.6M
- IPO Year
- USIO N/A
- COCH N/A
- Fundamental
- Price
- USIO $1.56
- COCH $1.69
- Analyst Decision
- USIO Strong Buy
- COCH Strong Buy
- Analyst Count
- USIO 2
- COCH 2
- Target Price
- USIO $5.00
- COCH $9.13
- AVG Volume (30 Days)
- USIO 50.2K
- COCH 15.5K
- Earning Date
- USIO 05-14-2025
- COCH 05-19-2025
- Dividend Yield
- USIO N/A
- COCH N/A
- EPS Growth
- USIO N/A
- COCH N/A
- EPS
- USIO 0.12
- COCH N/A
- Revenue
- USIO $82,931,840.00
- COCH $212,000.00
- Revenue This Year
- USIO $16.14
- COCH $36.00
- Revenue Next Year
- USIO $13.51
- COCH $16.67
- P/E Ratio
- USIO $13.17
- COCH N/A
- Revenue Growth
- USIO N/A
- COCH N/A
- 52 Week Low
- USIO $1.24
- COCH $1.21
- 52 Week High
- USIO $2.92
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- USIO 51.96
- COCH 71.21
- Support Level
- USIO $1.56
- COCH $1.48
- Resistance Level
- USIO $1.68
- COCH $1.71
- Average True Range (ATR)
- USIO 0.09
- COCH 0.14
- MACD
- USIO -0.01
- COCH 0.03
- Stochastic Oscillator
- USIO 47.83
- COCH 95.00
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.